Cepheid molecular testing

Ended Awarded Last action

Contract number
36C25924N0018
Awardee
Awarding agency
Obligated
-$471,535

Award facts

Contract value 0% obligated
$993,766.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sunnyvale, CA 94089, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 -$3,498
Supplemental Agreement for work within scope P00007 -$71,863
Funding Only Action P00006 -$140,889
Funding Only Action P00005 -$255,285
Funding Only Action P00004 -$32,446
Funding Only Action P00003 $60,000
Funding Only Action P00002 -$150,000
Funding Only Action P00001 $88,074
Original award $1,499,673

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 19, awarded a Blanket Purchase Agreement (BPA) call to Cepheid Inc. valued at $993,767 on October 1, 2023, with completion targeted for September 30, 2024. This firm fixed-price contract, executed through the General Services Administration's Multiple Award Schedule, supports Cepheid's provision of molecular testing solutions and diagnostic capabilities at the company's Sunnyvale, California facility. The award represents a continuation of the VA's reliance on Cepheid as a primary federal supplier of advanced molecular diagnostic systems, reagents, and test kits for infectious disease detection, including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions through its GeneXpert diagnostic platform.

This BPA call operates within the framework of Cepheid's broader federal contract portfolio, which includes substantial Indefinite Delivery Contracts with the VA across multiple VISNs. Notably, Cepheid maintains a $32.8 million single-award IDC with VISN 6 extending through September 30, 2030, and a $6.7 million IDC with VISN 17, both supporting ongoing procurement of diagnostic reagents and testing solutions across VA medical centers. The contract carries no small business set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics market. This award demonstrates the VA's continued investment in rapid, reliable diagnostic capabilities to support clinical laboratory operations and infectious disease testing across its distributed network of healthcare facilities.

Quick answers

Who was awarded contract 36C25924N0018?

36C25924N0018 was awarded to Cepheid by Veterans Integrated Service Network 19 (Veterans Health Administration) on October 1, 2023.

How much is contract 36C25924N0018 worth?

The government has obligated -$471,535 on 36C25924N0018. Its current value, with exercised options, is $993,767.

Is contract 36C25924N0018 an order under another contract?

Yes. 36C25924N0018 is a BPA call under GS07F0597T-36C25921A0003, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 36C25924N0018 competed?

The extent of competition for 36C25924N0018 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award